Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001386997 | SCV001587464 | pathogenic | not provided | 2022-09-10 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 190 of the RHO protein (p.Asp190Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant retinitis pigmentosa (PMID: 11141431, 29847639). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13040). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RHO protein function. Experimental studies have shown that this missense change affects RHO function (PMID: 30240733, 30977563). This variant disrupts the p.Asp190 amino acid residue in RHO. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1765377, 1862076, 24520188). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV000504953 | SCV004024608 | pathogenic | Retinitis pigmentosa | 2023-08-16 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000013915 | SCV000034162 | pathogenic | Retinitis pigmentosa 4 | 1992-05-01 | no assertion criteria provided | literature only | |
NIHR Bioresource Rare Diseases, |
RCV000504953 | SCV000598753 | likely pathogenic | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research |